Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study To Assess Pharmacodynamics, Safety And Tolerability Of PF-05221304 And PF-06865571 Co-Administered For 6 Weeks In Adults With Non-Alcoholic Fatty Liver Disease.

ClinicalTrials.gov ID: NCT03776175

Public ClinicalTrials.gov record NCT03776175. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 10:42 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 2A, RANDOMIZED, DOUBLE BLIND (SPONSOR-OPEN), PLACEBO CONTROLLED, PARALLEL GROUP STUDY TO ASSESS THE PHARMACODYNAMICS, SAFETY AND TOLERABILITY OF PF-05221304 AND PF-06865571 CO-ADMINISTERED FOR 6 WEEKS IN ADULTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)

Study identification

NCT ID
NCT03776175
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
99 participants

Conditions and interventions

Interventions

  • PF-05221304 Monotherapy Drug
  • PF-06865571 Monotherapy Drug
  • Placebo Drug
  • PF-05221304 and PF-06865571 Combination Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 3, 2019
Primary completion
Sep 8, 2019
Completion
Oct 10, 2019
Last update posted
Sep 22, 2020

2019

United States locations

U.S. sites
29
U.S. states
12
U.S. cities
25
Facility City State ZIP Site status
Franco Felizarta, Md Bakersfield California 93301
Westside Medical Associates of Los Angeles Beverly Hills California 90211
ProSciento, Inc. Chula Vista California 91911
National Research Institute - Wilshire Los Angeles California 90057
Catalina Research Institute, LLC Montclair California 91763
Floridian Clinical Research, LLC Hialeah Florida 33016
Research Centers of America, LLC Hollywood Florida 33024
Jacksonville Center for Clinical Research Jacksonville Florida 32216
Pharmax Research Clinic Miami Florida 33126
Omega Research Maitland Orlando Florida 32810
Accel Research Sites Orlando Florida 32819
Advanced Gastroenterology Associates, LLC Palm Harbor Florida 34684
QPS-MRA, LLC-Main Office South Miami Florida 33143
East-West Medical Research Institute Honolulu Hawaii 96814
Midwest Institute for Clinical Research Indianapolis Indiana 46260
Heartland Research Associates, LLC Wichita Kansas 67207
L-MARC Research Center Louisville Kentucky 40213
Clarity Clinical Research East Syracuse New York 13057
High Point Clinical Trials Center High Point North Carolina 27265
M3 Wake Research, Inc Raleigh North Carolina 27612
Wake Gastroenterology Raleigh North Carolina 27612
PMG Research of Wilmington, LLC Wilmington North Carolina 28401
Sterling Research Group - Mt. Auburn Cincinnati Ohio 45219
New Horizons Clinical Research Cincinnati Ohio 45242
WR-Clinsearch, LLC Chattanooga Tennessee 37421
New Orleans Center for Clinical Research Knoxville Tennessee 37920
University of Tennessee Medical Center - Radiology Knoxville Tennessee 37920
Clinical Trials of Texas, Inc. San Antonio Texas 78229
National Clinical Research-Richmond, Inc. Richmond Virginia 23294

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03776175, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 22, 2020 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03776175 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →